BioMedPartners announce the final closing of BioMedInvest II LP, its second healthcare venture capital fund, at CHF 106 Mio. and strengthens its management team.
BioMedPartners erhöht das Volumen des BioMedInvest II LP Funds auf CHF 106 Mio. und verstärkt ihr Management Team um Dr. Karl Deres als neuen Venture Partner.
Curetis AG closed it's Series A financing round of EUR 18.5 million (CHF 27.9 Mio.) with BioMedInvest II LP as co-lead-investor.
Activaero GmbH announces the closing of a Series A financing totalling EUR 10.7 Mio. (CHF 16.2 Mio.) with BioMedInvest II LP as lead-investor.
Evolva SA announces first closing of its Series B financing round of CHF 28 Mio. with BioMedInvest-II LP as co-investor.
BioMedPartners raise 95 Million for new healthcare venture fund.
